Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kapil Sethi

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Investigative and Clinical Urology|November 11, 2017
Thermo-expandable prostatic stents for bladder outlet obstruction in the frail and elderly population: An underutilized procedure?Kapil Sethi, Michael Bozin, Tebogo Jabane, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|June 1, 2013
Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical DystoniaHubert H Fernandez, Fernando Pagan, Fabio Danisi, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|August 15, 2014
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with BlepharospasmHubert H Fernandez, Joseph Jankovic, John B Holds, et al.
Parkinsonism & Related Disorders|February 20, 2018
The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?Kelvin L Chou, Mark Stacy, Tanya Simuni, et al.
The Lancet. Neurology|March 15, 2013
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trialRobert A Hauser, Ann Hsu, Sherron Kell, et al.
Journal of Movement Disorders|April 25, 2025
Safety and efficacy of istradefylline in Parkinson's disease patients with and without pre-existing dyskinesia: Pooled analysis of 8 randomized controlled trialsNobutaka Hattori, Lawrence Elmer, Stuart H Isaacson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2005
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessmentMark Stacy, Annette Bowron, Mark Guttman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's diseaseRay L Watts, Kelly E Lyons, Rajesh Pahwa, et al.
Plos One|July 8, 2017
Protective effect of zinc preconditioning against renal ischemia reperfusion injury is dose dependentKenny Rao, Kapil Sethi, Joseph Ischia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2015
Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)Rajesh Pahwa, Caroline M Tanner, Robert A Hauser, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Investigative and Clinical Urology|November 11, 2017
Thermo-expandable prostatic stents for bladder outlet obstruction in the frail and elderly population: An underutilized procedure?Kapil Sethi, Michael Bozin, Tebogo Jabane, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|June 1, 2013
Prospective Study Evaluating IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm: Interim Results from the First 145 Subjects with Cervical DystoniaHubert H Fernandez, Fernando Pagan, Fabio Danisi, et al.
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|August 15, 2014
Observational Study of IncobotulinumtoxinA for Cervical Dystonia or Blepharospasm (XCiDaBLE): Interim Results for the First 170 Subjects with BlepharospasmHubert H Fernandez, Joseph Jankovic, John B Holds, et al.
Parkinsonism & Related Disorders|February 20, 2018
The spectrum of "off" in Parkinson's disease: What have we learned over 40 years?Kelvin L Chou, Mark Stacy, Tanya Simuni, et al.
The Lancet. Neurology|March 15, 2013
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trialRobert A Hauser, Ann Hsu, Sherron Kell, et al.
Journal of Movement Disorders|April 25, 2025
Safety and efficacy of istradefylline in Parkinson's disease patients with and without pre-existing dyskinesia: Pooled analysis of 8 randomized controlled trialsNobutaka Hattori, Lawrence Elmer, Stuart H Isaacson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2005
Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessmentMark Stacy, Annette Bowron, Mark Guttman, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 13, 2010
Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's diseaseRay L Watts, Kelly E Lyons, Rajesh Pahwa, et al.
Plos One|July 8, 2017
Protective effect of zinc preconditioning against renal ischemia reperfusion injury is dose dependentKenny Rao, Kapil Sethi, Joseph Ischia, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2015
Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)Rajesh Pahwa, Caroline M Tanner, Robert A Hauser, et al.
Pageof 4